PP_1170x120_10-25-21

hydroxychloroquine

NABP: Illegal online pharmacies exploit vulnerable consumers during the COVID-19 pandemic

NABP: Illegal online pharmacies exploit vulnerable consumers during the COVID-19 pandemic

MOUNT PROSPECT, Ill. — The National Association of Boards of Pharmacy (NABP) released the May 2020 Rogue Rx Activity Report, Rogue Online Pharmacies in the Time of Pandemic: Capitalizing on Misinformation and Fear. The report highlights how illegal online pharmacies use COVID-19 to expand operations and prey on consumer fears. NABP has identified dozens of

Hydroxychloroquine secured by Valor Compounding Pharmacy

Hydroxychloroquine secured by Valor Compounding Pharmacy

BERKELEY, Calif. — Valor Compounding Pharmacy has obtained hydroxychloroquine in an effort to offer continued treatment for patients with lupus, malaria, rheumatoid arthritis, and other medical applications. Valor developed a plan to reasonably dispense the medication so as not to jeopardize the needs of patients with chronic conditions. Valor recognized that this pharmaceutical ingredient would quickly be in high

NIH clinical trial to evaluate the safety and effectiveness of hydroxychloroquine begins

NIH clinical trial to evaluate the safety and effectiveness of hydroxychloroquine begins

NEW YORK — A clinical trial to evaluate the safety and effectiveness of hydroxychloroquine for the treatment of adults hospitalized with coronavirus disease 2019 (COVID-19) has begun, with the first participants now enrolled in Tennessee. The Outcomes Related to COVID-19 treated with hydroxychloroquine among In-patients with symptomatic Disease study, or ORCHID Study, is being conducted